DK1343766T3 - Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner - Google Patents
Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridinerInfo
- Publication number
- DK1343766T3 DK1343766T3 DK01990192T DK01990192T DK1343766T3 DK 1343766 T3 DK1343766 T3 DK 1343766T3 DK 01990192 T DK01990192 T DK 01990192T DK 01990192 T DK01990192 T DK 01990192T DK 1343766 T3 DK1343766 T3 DK 1343766T3
- Authority
- DK
- Denmark
- Prior art keywords
- naphthyridines
- quinolones
- cyclization
- preparation
- process step
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25563300P | 2000-12-14 | 2000-12-14 | |
PCT/US2001/048536 WO2002048113A1 (en) | 2000-12-14 | 2001-12-07 | Cyclization process step in the making of quinolones and naphthyridines |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1343766T3 true DK1343766T3 (da) | 2005-10-31 |
Family
ID=22969207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01990192T DK1343766T3 (da) | 2000-12-14 | 2001-12-07 | Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1343766B1 (da) |
JP (2) | JP4417007B2 (da) |
KR (1) | KR100603163B1 (da) |
CN (1) | CN1232508C (da) |
AT (1) | ATE300522T1 (da) |
AU (2) | AU2002229057B2 (da) |
BR (1) | BR0116229A (da) |
CA (1) | CA2427831C (da) |
CZ (1) | CZ20031379A3 (da) |
DE (1) | DE60112325T2 (da) |
DK (1) | DK1343766T3 (da) |
ES (1) | ES2247190T3 (da) |
HU (1) | HUP0303991A3 (da) |
IL (2) | IL155677A0 (da) |
MX (1) | MXPA03005338A (da) |
NO (1) | NO325236B1 (da) |
NZ (1) | NZ525569A (da) |
PL (1) | PL207394B1 (da) |
WO (1) | WO2002048113A1 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100735587B1 (ko) * | 2002-08-05 | 2007-07-04 | 더 프록터 앤드 갬블 캄파니 | 퀴놀론계 항생제 중간체의 제조 방법 |
US6803469B2 (en) | 2002-08-05 | 2004-10-12 | The Procter & Gamble Company | Process for preparing quinolone antibiotic intermediates |
EP1564210B9 (en) | 2002-11-20 | 2010-03-31 | Japan Tobacco Inc. | 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
US7402674B2 (en) | 2004-01-31 | 2008-07-22 | Sanofi-Aventis Deutschland Gmbh, | 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
CN101437801B (zh) | 2006-03-06 | 2013-02-06 | 日本烟草产业株式会社 | 制备4-氧代喹啉化合物的方法 |
BRPI0708685B8 (pt) | 2006-03-06 | 2021-05-25 | Japan Tobacco Inc | composto de 4-oxoquinolina, seu uso e método para produção dos mesmos |
EP2644587A3 (en) | 2006-09-12 | 2013-10-23 | Gilead Sciences, Inc. | Process and intermediates for preparing integrase inhibitors |
US8658183B2 (en) | 2007-08-09 | 2014-02-25 | Taigen Biotechnology Company, Ltd. | Antimicrobial parenteral formulation |
AR068403A1 (es) | 2007-09-11 | 2009-11-18 | Gilead Sciences Inc | Proceso e intermediarios para la preparacion de inhibidores de integrasa |
TR201820964T4 (tr) | 2008-07-01 | 2019-01-21 | Taigen Biotechnology Co Ltd | Antibiyotiğe karşı dirençli bakteri enfeksiyonunun tedavisi. |
SG11201500812QA (en) | 2012-08-03 | 2015-04-29 | Gilead Sciences Inc | Process and intermediates for preparing integrase inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9700871A (es) * | 1994-08-02 | 1997-05-31 | Procter & Gamble | Procedimiento para hacer compuestos antimicrobianos. |
WO1996004286A1 (en) * | 1994-08-02 | 1996-02-15 | The Procter & Gamble Company | Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
-
2001
- 2001-12-07 DE DE60112325T patent/DE60112325T2/de not_active Expired - Lifetime
- 2001-12-07 JP JP2002549644A patent/JP4417007B2/ja not_active Expired - Fee Related
- 2001-12-07 CA CA002427831A patent/CA2427831C/en not_active Expired - Fee Related
- 2001-12-07 AT AT01990192T patent/ATE300522T1/de active
- 2001-12-07 BR BR0116229-2A patent/BR0116229A/pt not_active IP Right Cessation
- 2001-12-07 EP EP01990192A patent/EP1343766B1/en not_active Expired - Lifetime
- 2001-12-07 ES ES01990192T patent/ES2247190T3/es not_active Expired - Lifetime
- 2001-12-07 WO PCT/US2001/048536 patent/WO2002048113A1/en active IP Right Grant
- 2001-12-07 DK DK01990192T patent/DK1343766T3/da active
- 2001-12-07 PL PL363355A patent/PL207394B1/pl not_active IP Right Cessation
- 2001-12-07 NZ NZ525569A patent/NZ525569A/en not_active IP Right Cessation
- 2001-12-07 AU AU2002229057A patent/AU2002229057B2/en not_active Ceased
- 2001-12-07 CZ CZ20031379A patent/CZ20031379A3/cs unknown
- 2001-12-07 IL IL15567701A patent/IL155677A0/xx active IP Right Grant
- 2001-12-07 KR KR1020037007905A patent/KR100603163B1/ko not_active IP Right Cessation
- 2001-12-07 AU AU2905702A patent/AU2905702A/xx active Pending
- 2001-12-07 CN CNB018207146A patent/CN1232508C/zh not_active Expired - Lifetime
- 2001-12-07 MX MXPA03005338A patent/MXPA03005338A/es active IP Right Grant
- 2001-12-07 HU HU0303991A patent/HUP0303991A3/hu unknown
-
2003
- 2003-04-30 IL IL155677A patent/IL155677A/en not_active IP Right Cessation
- 2003-06-12 NO NO20032667A patent/NO325236B1/no not_active IP Right Cessation
-
2009
- 2009-10-05 JP JP2009231801A patent/JP2010001315A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2002229057B2 (en) | 2005-04-21 |
JP4417007B2 (ja) | 2010-02-17 |
MXPA03005338A (es) | 2003-10-06 |
EP1343766B1 (en) | 2005-07-27 |
WO2002048113A1 (en) | 2002-06-20 |
ATE300522T1 (de) | 2005-08-15 |
AU2905702A (en) | 2002-06-24 |
CA2427831C (en) | 2009-08-18 |
IL155677A (en) | 2009-02-11 |
CN1481365A (zh) | 2004-03-10 |
NZ525569A (en) | 2004-09-24 |
IL155677A0 (en) | 2003-11-23 |
CN1232508C (zh) | 2005-12-21 |
NO325236B1 (no) | 2008-03-03 |
NO20032667D0 (no) | 2003-06-12 |
CA2427831A1 (en) | 2002-06-20 |
JP2010001315A (ja) | 2010-01-07 |
HUP0303991A2 (hu) | 2004-04-28 |
DE60112325T2 (de) | 2006-05-24 |
NO20032667L (no) | 2003-08-14 |
CZ20031379A3 (cs) | 2003-11-12 |
PL207394B1 (pl) | 2010-12-31 |
ES2247190T3 (es) | 2006-03-01 |
BR0116229A (pt) | 2003-11-04 |
KR20030063420A (ko) | 2003-07-28 |
EP1343766A1 (en) | 2003-09-17 |
DE60112325D1 (de) | 2005-09-01 |
KR100603163B1 (ko) | 2006-07-24 |
HUP0303991A3 (en) | 2012-09-28 |
JP2004515542A (ja) | 2004-05-27 |
PL363355A1 (en) | 2004-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1070056E (pt) | Inibidores de pde iii/iv a base de ftalazinona | |
RS86804A (en) | Quinoline and isoquinoline derivatives method for the production thereof and use therof as anti-inflammatory agents | |
NO20024869L (no) | Oksygenatomdanningsprosess | |
DK1343766T3 (da) | Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner | |
NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
SE0103710D0 (sv) | Compounds | |
DK1373255T3 (da) | Fremgangsmåde til fremstilling af imidazolforbindelser | |
MY141871A (en) | A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones | |
DK1335913T3 (da) | Fremgangsmåde til fremstilling af pantoprazol og intermediære deraf | |
DK1206452T3 (da) | Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser | |
TR200402546T4 (tr) | Taksan türevleri hazırlamak için işlem. | |
MXPA04000771A (es) | Metodo para nitracion de compuestos fenolicos. | |
MXPA02001406A (es) | Heterociclilos-2h-cromenos substituidos. | |
DK1280752T3 (da) | Fremgangsmåde til fremstilling af 2-alkyl-3-chlorphenoler | |
DE60043228D1 (de) | Herstellungsverfahren von 2-cyanopyridinen | |
DK1250335T3 (da) | Fremgangsmåde og mellemprodukter til fremstilling af imidazopyridiner | |
DK1085019T3 (da) | Omoprazolsyntese | |
SE0101323D0 (sv) | New process | |
DK1320527T3 (da) | Fremgangsmåde til fremstilling af 1-substituerede 5-chlor-4-methylpytrazoler | |
SE0000382D0 (sv) | New process | |
WO2003044877A3 (en) | Light emitting device and compounds for use therein | |
NO20033840D0 (no) | Fremgangsmåte for fremstilling av mirtazapinmellomprodukter | |
DK1315702T3 (da) | Fremgangsmåde til fremstilling af halogen-4-phenoxyquinoliner | |
DK1171542T3 (da) | Fremgangsmåde til fremstilling af oxygenfjernende forseglingsmiddelsammensætninger | |
DK0949250T3 (da) | Fremgangsmåde til fremstilling af alpha1L-adrenoceptorantagonister |